Announced Sat, 5 Sept · 13:09 IST

Asston Pharma allots 24.10 lakh shares at Rs 115 via preferential route

Qip At PremiumFund Raising View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹110.00
prior close
₹115.40
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-9.0-9.0-9.0-2.9+0.0-1.6-2.7-0.9-0.1-1.0
Up moveDown movePending
AI summary

Board approved allotment of 24,10,431 equity shares at Rs 115 each (face value Rs 10, premium of Rs 105) to 15 public-category allottees via preferential allotment. Top allottees: Vijay Rathee (13,17,391 shares) and Vijaylaxmi Infra Projects (7,82,608 shares). Post-allotment paid-up equity capital rises to Rs 10,92,27,910 comprising 1,09,22,791 shares. Board meeting ran 10:30 to 10:45 AM on Sept 5, 2026.

Likely market impact

About 22 percent equity dilution for existing holders. Shares issued at 10.5x face value. Deployment of the roughly Rs 27.7 crore raised will be key to track.